Financing
Payment of Deferred Purchase Consideration
Edwards Lifesciences Payment of Deferred Purchase Consideration increased by 154.8% to $1.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 142.9%, from $700.00K to $1.70M. Over 2 years (FY 2022 to FY 2025), Payment of Deferred Purchase Consideration shows relatively stable performance with a -1.3% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026May 6, 2026
Metric ID:
isrg_payment_of_deferred_purchase_considerationHistorical Data
17 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$100.00K | $0.00 | -$2.00M | -$1.90M | $0.00 | $800.00K | -$1.20M | -$2.90M | -$200.00K | $7.20M | -$10.20M | $0.00 | $700.00K | $1.00M | -$2.40M | -$3.10M | $1.70M |
| QoQ Change | — | +100.0% | — | +5.0% | +100.0% | — | -250.0% | -141.7% | +93.1% | >999% | -241.7% | +100.0% | — | +42.9% | -340.0% | -29.2% | +154.8% |
| YoY Change | — | — | <-999% | — | — | — | +40.0% | -52.6% | -125.0% | +700.0% | -251.7% | — | +450.0% | -86.1% | +76.5% | — | +142.9% |
Range-$10.20M – $7.20M
CAGR+103.1%
Avg YoY Growth-100.6%
Median YoY Growth-6.3%
Payment of Deferred Purchase Consideration at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's payment of deferred purchase consideration?
- Edwards Lifesciences (EW) reported payment of deferred purchase consideration of $1.70M in Q1 2026.
- How has Edwards Lifesciences's payment of deferred purchase consideration changed year-over-year?
- Edwards Lifesciences's payment of deferred purchase consideration increased by 142.9% year-over-year, from $700.00K to $1.70M.
- What is the long-term trend for Edwards Lifesciences's payment of deferred purchase consideration?
- Over 2 years (2022 to 2025), Edwards Lifesciences's payment of deferred purchase consideration has grown at a -1.3% compound annual growth rate (CAGR), from -$3.90M to -$3.80M.